Canaccord Genuity Raises Illumina's Price Target to $99, Maintains Hold Rating
Jun 12, 2025 11:50
CST Updated
11:50
Illumina
Diagnostic Product Developer
Gelonghui June 12 | Canaccord Genuity raised Illumina's target price from $87 to $99 and maintained a "Hold" rating. (Gelonghui)